High Health-Related Quality of Life During Dendritic Cell Vaccination Therapy in Patients With Castration-Resistant Prostate Cancer

BackgroundMaintaining health-related quality of life (HRQoL) is highly desirable during systemic therapies for patients with castration-resistant prostate cancer (CRPC). Patient-reported outcome measures (PROs) were studied in our phase IIa trial on cellular-based immunotherapy with dendritic cells...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Harm Westdorp, Jeroen H. A. Creemers, Inge M. van Oort, Niven Mehra, Simone M. Hins-de Bree, Carl G. Figdor, J. Alfred Witjes, Gerty Schreibelt, I. Jolanda M. de Vries, Winald R. Gerritsen, Petronella B. Ottevanger
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2020-10-01
Edice:	Frontiers in Oncology
Témata:	health-related quality of life (HRQoL) patient-reported outcomes (PROs) dendritic cell vaccination immunotherapy castration-resistant prostate cancer
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fonc.2020.536700/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!